Kane Biotech Inc. (TSXV:KNE)
Canada · Delayed Price · Currency is CAD 0.0300
+0.0050 (20.00%)
Aug 28, 2026, 2:46 PM EST
Kane Biotech Market Cap
Kane Biotech has a market cap or net worth of CAD 6.16 million as of August 28, 2026. Its market cap has decreased by -7.28% in one year.
Market Cap
6.16M
Enterprise Value
7.26M
Revenue
38.72K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
ChartMarket Cap Chart
Since May 20, 2003, Kane Biotech's market cap has increased from 1.03M to 6.16M, an increase of 498.68%. That is a compound annual growth rate of 7.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 6.16M | -15.25% |
| Dec 30, 2025 | 7.26M | -51.98% |
| Dec 31, 2024 | 15.13M | 43.41% |
| Dec 29, 2023 | 10.55M | -6.12% |
| Dec 30, 2022 | 11.23M | -36.87% |
| Dec 31, 2021 | 17.80M | 17.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Marvel Biosciences | 9.77M |
| Glow Lifetech | 7.70M |
| XORTX Therapeutics | 5.54M |
| PharmaTher Holdings | 5.46M |
| Rakovina Therapeutics | 5.37M |
| MYND Life Sciences | 5.22M |
| Grey Matters Health | 4.46M |
| Restart Life Sciences | 4.36M |